RU2001131111A - NEW COMPOUNDS, THEIR PRODUCTION AND APPLICATION - Google Patents
NEW COMPOUNDS, THEIR PRODUCTION AND APPLICATION Download PDFInfo
- Publication number
- RU2001131111A RU2001131111A RU2001131111/04A RU2001131111A RU2001131111A RU 2001131111 A RU2001131111 A RU 2001131111A RU 2001131111/04 A RU2001131111/04 A RU 2001131111/04A RU 2001131111 A RU2001131111 A RU 2001131111A RU 2001131111 A RU2001131111 A RU 2001131111A
- Authority
- RU
- Russia
- Prior art keywords
- alkyl
- phenyl
- compound according
- preceding paragraphs
- alkenyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
- C07D213/30—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
- C07C59/64—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
- C07C59/66—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings
- C07C59/68—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings the oxygen atom of the ether group being bound to a non-condensed six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
- C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
- C07C69/734—Ethers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/40—Radicals substituted by oxygen atoms
- C07D307/42—Singly bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
- C07D333/16—Radicals substituted by singly bound hetero atoms other than halogen by oxygen atoms
Claims (49)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DKPA199900533 | 1999-04-20 | ||
DKPA199900533 | 1999-04-20 |
Publications (1)
Publication Number | Publication Date |
---|---|
RU2001131111A true RU2001131111A (en) | 2003-08-10 |
Family
ID=8094620
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2001131111/04A RU2001131111A (en) | 1999-04-20 | 2000-04-17 | NEW COMPOUNDS, THEIR PRODUCTION AND APPLICATION |
Country Status (16)
Country | Link |
---|---|
EP (1) | EP1171414A1 (en) |
JP (1) | JP2002542218A (en) |
KR (1) | KR20020005703A (en) |
CN (1) | CN1348439A (en) |
AU (1) | AU3958000A (en) |
BR (1) | BR0009864A (en) |
CA (1) | CA2367356A1 (en) |
CZ (1) | CZ20013558A3 (en) |
HU (1) | HUP0200807A3 (en) |
IL (1) | IL145789A0 (en) |
NO (1) | NO20015113L (en) |
PL (1) | PL351312A1 (en) |
RU (1) | RU2001131111A (en) |
TW (1) | TW553931B (en) |
WO (1) | WO2000063153A1 (en) |
ZA (1) | ZA200107983B (en) |
Families Citing this family (59)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6555577B1 (en) | 2000-01-28 | 2003-04-29 | Novo Nordisk A/S | Compounds, their preparation and use |
JP2003520838A (en) * | 2000-01-28 | 2003-07-08 | ノボ ノルディスク アクティーゼルスカブ | New compounds, their manufacture and use. |
JP2003525908A (en) | 2000-03-08 | 2003-09-02 | ノボ ノルディスク アクティーゼルスカブ | Low serum lipids |
EP1911462A3 (en) | 2001-01-26 | 2011-11-30 | Schering Corporation | Compositions comprising a sterol absorption inhibitor |
US6869967B2 (en) | 2001-07-30 | 2005-03-22 | Novo Nordisk A/S | Peroxisome proliferator-activated receptor (PPAR) active vinyl carboxylic acid derivatives |
US7067530B2 (en) | 2001-07-30 | 2006-06-27 | Novo Nordisk A/S | Compounds, their preparation and use |
JP2004536150A (en) * | 2001-07-30 | 2004-12-02 | ノボ ノルディスク アクティーゼルスカブ | Novel vinyl, carboxylic acid derivatives and their use as antibiotics etc. |
JP2004536152A (en) * | 2001-07-30 | 2004-12-02 | ノボ ノルディスク アクティーゼルスカブ | Novel vinyl N- (2-benzoylphenyl) -L-tyrosine derivatives and their use for antidiabetic agents and the like |
EP1414806A1 (en) * | 2001-07-30 | 2004-05-06 | Novo Nordisk A/S | Novel vinyl n-(2-benzoylphenyl)-l-tyrosine derivatives and their use as antidiabetics etc |
JP4563675B2 (en) | 2001-10-12 | 2010-10-13 | ハイ・ポイント・ファーマスーティカルズ、エルエルシー | Substituted piperidines and their use for the treatment of histamine H3 receptor related diseases |
BR0215212A (en) | 2001-12-21 | 2004-12-07 | Novo Nordisk As | Carboxamide or glycoside sulfonamide activator, compound, pharmaceutical composition, and use of a compound |
US7015345B2 (en) | 2002-02-21 | 2006-03-21 | Asahi Kasei Pharma Corporation | Propionic acid derivatives |
US6716842B2 (en) | 2002-04-05 | 2004-04-06 | Warner-Lambert Company, Llc | Antidiabetic agents |
KR101116627B1 (en) | 2002-06-27 | 2012-10-09 | 노보 노르디스크 에이/에스 | Aryl carbonyl derivatives as therapeutic agents |
PL375700A1 (en) * | 2002-09-05 | 2005-12-12 | Novo Nordisk A/S | Novel vinyl carboxylic acid derivatives and their therapeutical use |
US7129268B2 (en) * | 2002-10-28 | 2006-10-31 | Novo Nordisk A/S | Peroxisome proliferator activated receptor-active arylene acetic acid derivatives |
KR20050055790A (en) * | 2002-10-28 | 2005-06-13 | 노보 노르디스크 에이/에스 | Novel compounds useful in treating ppar mediated diseases |
CN100491316C (en) | 2002-10-28 | 2009-05-27 | 高点制药有限责任公司 | Novel compounds, their preparation and use |
EP1558572B1 (en) * | 2002-10-28 | 2010-06-30 | High Point Pharmaceuticals, LLC | Novel compounds and their use as prar-modulators |
US7816385B2 (en) | 2002-12-20 | 2010-10-19 | High Point Pharmaceuticals, Llc | Dimeric dicarboxylic acid derivatives, their preparation and use |
EP1578716A1 (en) * | 2002-12-20 | 2005-09-28 | Novo Nordisk A/S | Dicarboxylic acid derivatives as ppar-agonists |
DE602004022153D1 (en) | 2003-05-14 | 2009-09-03 | High Point Pharmaceuticals Llc | COMPOUNDS FOR THE TREATMENT OF OBESITAS |
DE602004022179D1 (en) | 2003-09-19 | 2009-09-03 | Janssen Pharmaceutica Nv | 4 - ((PHENOXYALKYL) THIO) -PHENOXY ACETIC ACIDS AND ANALOGUES |
MXPA06003474A (en) | 2003-09-30 | 2006-06-05 | Novo Nordisk As | Melanocortin receptor agonists. |
EP1694356B1 (en) | 2003-12-09 | 2011-02-16 | Novo Nordisk A/S | Regulation of food preference using glp-1 agonists |
DK1723128T3 (en) | 2004-01-06 | 2013-02-18 | Novo Nordisk As | Heteroarlurines and their use as glucokinase activators |
JP2007536344A (en) | 2004-05-04 | 2007-12-13 | ノボ ノルディスク アクティーゼルスカブ | New indole derivatives |
WO2005105725A1 (en) * | 2004-05-05 | 2005-11-10 | Novo Nordisk A/S | Novel compounds, their preparation and use |
ATE515494T1 (en) | 2004-05-05 | 2011-07-15 | High Point Pharmaceuticals Llc | NEW COMPOUNDS, THEIR PRODUCTION AND USE |
CN1950078A (en) | 2004-06-11 | 2007-04-18 | 诺和诺德公司 | Counteracting drug-induced obesity using glp-1 agonists |
JP4874989B2 (en) | 2004-11-22 | 2012-02-15 | ノヴォ ノルディスク アー/エス | Soluble and stable insulin-containing formulation |
CA2590720A1 (en) | 2004-12-03 | 2006-06-08 | Lone Jeppesen | Heteroaromatic glucokinase activators |
FR2882359A1 (en) * | 2005-02-24 | 2006-08-25 | Negma Lerads Soc Par Actions S | New phenyl compounds are peroxisome proliferator activated receptor activators useful to treat hyperlipidemia and atherosclerosis |
WO2006091047A1 (en) * | 2005-02-25 | 2006-08-31 | Heonjoong Kang | Thiazole derivatives as ppar delta ligands and their manufacturing process |
AU2006264966B2 (en) | 2005-07-04 | 2013-02-21 | High Point Pharmaceuticals, Llc | Histamine H3 receptor antagonists |
JP4960355B2 (en) | 2005-07-14 | 2012-06-27 | ノボ・ノルデイスク・エー/エス | Urea-type glucokinase activator |
ES2426345T3 (en) | 2005-07-20 | 2013-10-22 | Eli Lilly And Company | Compound bound in 1-amino position |
PL1951658T3 (en) | 2005-11-17 | 2013-02-28 | Lilly Co Eli | Glucagon receptor antagonists, preparation and therapeutic uses |
EP2386540A1 (en) | 2005-12-22 | 2011-11-16 | High Point Pharmaceuticals, LLC | Novel compounds, their preparation and use |
KR101280333B1 (en) | 2006-03-28 | 2013-07-02 | 하이 포인트 파마슈티칼스, 엘엘씨 | Benzothiazoles having histamine h3 receptor activity |
CA2659570C (en) | 2006-05-29 | 2015-10-06 | High Point Pharmaceuticals, Llc | 3-(1,3-benzodioxol-5-yl)-6-(4-cyclopropylpiperazin-1-yl)-pyridazine, its salts and solvates and its use as histamine h3 receptor antagonist |
ES2377322T3 (en) | 2006-11-15 | 2012-03-26 | High Point Pharmaceuticals, Llc | New 2- (2-hydroxyphenyl) benzothiadiazines useful for the treatment of obesity and diabetes |
ATE523497T1 (en) | 2006-11-15 | 2011-09-15 | High Point Pharmaceuticals Llc | NEW 2-(2-HYDROXYPHENYL)BENZIMIDAZOLES SUITABLE FOR THE TREATMENT OF OBESITAS AND DIABETES |
AU2008204530B2 (en) | 2007-01-11 | 2013-08-01 | Vtv Therapeutics Llc | Urea glucokinase activators |
US20130012432A1 (en) | 2010-02-26 | 2013-01-10 | Novo Nordisk A/S | Peptides for Treatment of Obesity |
BR112012021231A2 (en) | 2010-02-26 | 2015-09-08 | Basf Plant Science Co Gmbh | method for enhancing plant yield, plant, construct, use of a construct, method for producing a transgenic plant, collectable parts of a plant, products derived from a plant, use of a nucleic acid and method for producing a product |
RU2559320C2 (en) | 2010-03-26 | 2015-08-10 | Ново Нордиск А/С | Novel glucagon analogues |
US20130156720A1 (en) | 2010-08-27 | 2013-06-20 | Ironwood Pharmaceuticals, Inc. | Compositions and methods for treating or preventing metabolic syndrome and related diseases and disorders |
EP2670368A4 (en) | 2011-02-03 | 2015-04-15 | Pharmedica Ltd | New oral dissolving films for insulin administration, for treating diabetes |
AU2012234276A1 (en) | 2011-03-28 | 2013-08-29 | Novo Nordisk A/S | Novel glucagon analogues |
TWI596110B (en) | 2011-09-23 | 2017-08-21 | 諾佛 儂迪克股份有限公司 | Novel glucagon analogues |
WO2014170496A1 (en) | 2013-04-18 | 2014-10-23 | Novo Nordisk A/S | Stable, protracted glp-1/glucagon receptor co-agonists for medical use |
CN106536547A (en) | 2014-06-04 | 2017-03-22 | 诺和诺德股份有限公司 | GLP-1/glucagon receptor co-agonists for medical use |
CN107915701B (en) * | 2016-10-10 | 2020-09-29 | 沈阳药科大学 | PPAR alpha/gamma dual agonist and application thereof |
CN111032680A (en) | 2017-03-15 | 2020-04-17 | 诺和诺德股份有限公司 | Bicyclic compounds capable of binding to melanocortin 4 receptor |
WO2019219714A1 (en) | 2018-05-15 | 2019-11-21 | Novo Nordisk A/S | Compounds capable of binding to melanocortin 4 receptor |
WO2020053414A1 (en) | 2018-09-14 | 2020-03-19 | Novo Nordisk A/S | Bicyclic compounds capable of acting as melanocortin 4 receptor agonists |
CA3185909A1 (en) | 2020-07-22 | 2022-01-27 | Reneo Pharmaceuticals, Inc. | Crystalline ppar-delta agonist |
WO2023147309A1 (en) | 2022-01-25 | 2023-08-03 | Reneo Pharmaceuticals, Inc. | Use of ppar-delta agonists in the treatment of disease |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996004261A1 (en) * | 1994-07-29 | 1996-02-15 | Smithkline Beecham Plc | Benzoxazoles and pryridine derivatives useful in the treatment of the type ii diabetes |
GB9600464D0 (en) * | 1996-01-09 | 1996-03-13 | Smithkline Beecham Plc | Novel method |
GB9604242D0 (en) * | 1996-02-28 | 1996-05-01 | Glaxo Wellcome Inc | Chemical compounds |
DE69815008T2 (en) * | 1997-09-19 | 2004-04-01 | Ssp Co., Ltd. | Alpha-substituted phenylpropionic acid derivatives and medicaments containing them |
WO1999020614A1 (en) * | 1998-05-27 | 1999-04-29 | Dr. Reddy's Research Foundation | Bicyclic compounds, process for their preparation and pharmaceutical compositions containing them |
WO1999019313A1 (en) * | 1997-10-27 | 1999-04-22 | Dr. Reddy's Research Foundation | Novel tricyclic compounds and their use in medicine; process for their preparation and pharmaceutical compositions containing them |
CN1280574A (en) * | 1997-10-27 | 2001-01-17 | 雷迪研究基金会 | New heterocyclic compounds and their use in medicine, process for their prepartion and pharmaceutical compositions containing them |
AU1887999A (en) * | 1998-01-29 | 1999-08-16 | Dr. Reddy's Research Foundation | Novel alkanoic acids and their use in medicine, process for their preparation and pharmaceutical compositions containing them |
AU1120599A (en) * | 1998-04-23 | 1999-03-08 | Dr. Reddy's Research Foundation | New heterocyclic compounds and their use in medicine, process for their reparation and pharmaceutical compositions containing them |
-
2000
- 2000-04-17 JP JP2000612250A patent/JP2002542218A/en active Pending
- 2000-04-17 AU AU39580/00A patent/AU3958000A/en not_active Abandoned
- 2000-04-17 CN CN00806561A patent/CN1348439A/en active Pending
- 2000-04-17 CA CA002367356A patent/CA2367356A1/en not_active Abandoned
- 2000-04-17 KR KR1020017013417A patent/KR20020005703A/en not_active Application Discontinuation
- 2000-04-17 CZ CZ20013558A patent/CZ20013558A3/en unknown
- 2000-04-17 HU HU0200807A patent/HUP0200807A3/en unknown
- 2000-04-17 RU RU2001131111/04A patent/RU2001131111A/en not_active Application Discontinuation
- 2000-04-17 EP EP00918725A patent/EP1171414A1/en not_active Withdrawn
- 2000-04-17 BR BR0009864-7A patent/BR0009864A/en not_active IP Right Cessation
- 2000-04-17 PL PL00351312A patent/PL351312A1/en not_active Application Discontinuation
- 2000-04-17 WO PCT/DK2000/000190 patent/WO2000063153A1/en not_active Application Discontinuation
- 2000-04-17 IL IL14578900A patent/IL145789A0/en unknown
- 2000-05-02 TW TW089108460A patent/TW553931B/en not_active IP Right Cessation
-
2001
- 2001-09-28 ZA ZA200107983A patent/ZA200107983B/en unknown
- 2001-10-19 NO NO20015113A patent/NO20015113L/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CA2367356A1 (en) | 2000-10-26 |
CN1348439A (en) | 2002-05-08 |
NO20015113D0 (en) | 2001-10-19 |
WO2000063153A1 (en) | 2000-10-26 |
KR20020005703A (en) | 2002-01-17 |
EP1171414A1 (en) | 2002-01-16 |
PL351312A1 (en) | 2003-04-07 |
JP2002542218A (en) | 2002-12-10 |
IL145789A0 (en) | 2002-07-25 |
AU3958000A (en) | 2000-11-02 |
BR0009864A (en) | 2002-01-08 |
TW553931B (en) | 2003-09-21 |
HUP0200807A3 (en) | 2003-03-28 |
CZ20013558A3 (en) | 2002-05-15 |
HUP0200807A2 (en) | 2002-07-29 |
ZA200107983B (en) | 2002-05-29 |
NO20015113L (en) | 2001-12-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2001131111A (en) | NEW COMPOUNDS, THEIR PRODUCTION AND APPLICATION | |
RU2000131183A (en) | OXYMINO-ALKANIC ACID DERIVATIVES | |
RU2008123000A (en) | COMPOUNDS FOR TREATMENT OF METABOLIC DISORDERS | |
RU2312106C2 (en) | Substituted 4-alkoxyoxazol derivatives as ppar agonists | |
RU2010126105A (en) | Pyridine derivatives substituted by a heterocyclic ring and a phosphonoxymethyl group and containing antifungal agents | |
RU2005128501A (en) | COMPOUND FOR TREATMENT OF METABOLIC DISORDERS | |
RU2003121236A (en) | AILATED AMIDES OF FURAN- AND THIOPHENCARBOXYLIC ACIDS WITH LOCKING POTASSIUM CHANNEL ACTION | |
RU2004105956A (en) | NEW VINYL CARBOXYLIC ACID DERIVATIVES AND THEIR APPLICATION AS ANTI-DIABETIC MEDICINES, etc. | |
RU2008119465A (en) | CYCLOPROPYLAXUS ACID DERIVATIVES AND THEIR APPLICATION | |
RU2003134150A (en) | OXAZOLE DERIVATIVES REPLACED BY CARBONIC ACIDS AS PPAR-ALPHA AND GAMMA ACTIVATORS IN TREATMENT OF DIABETES | |
RU95118725A (en) | OXAZOLIDINDION DERIVATIVES, THEIR PRODUCTION AND PHARMACEUTICAL COMPOSITION | |
RU2003137578A (en) | AROMATIC DICARBOXYLIC ACID DERIVATIVES | |
CA2536136A1 (en) | Aryloxy and arylalkyleneoxy substituted imidazoquinolines | |
KR940019699A (en) | Oxazolidinedione derivatives, preparation method and use thereof | |
RU2011129555A (en) | ORGANIC COMPOUNDS | |
RU2004114875A (en) | DICARBOXYLIC ACID DERIVATIVES, THEIR PRODUCTION AND THERAPEUTIC USE | |
RU2006119776A (en) | BENZO DERIVATIVES {B} {1, 4} DIOXEPINE | |
RU2008119651A (en) | DICARBOXYLIC ACID DERIVATIVES AND THEIR APPLICATION | |
RU2005125284A (en) | 2-PIPERIDONE DERIVATIVES AS PROSTAGLANDINE AGONISTS | |
RU2010154502A (en) | TRICYCLIC 2,4-DIAMINO-L, 3,5-TRIAZINE DERIVATIVES USED FOR THE TREATMENT OF MALIGNANT NEW FORMATION AND MYELOPROLIFERAL DISORDERS | |
RU2005135441A (en) | COMPOUNDS FOR TREATMENT OF METABOLIC DISORDERS | |
RU2008119994A (en) | POTASSIUM CHANNEL INHIBITORS | |
RU2009136996A (en) | TRICYCLIC COMPOUNDS THAT CAN BE USED FOR TREATING DISORDERS RELATED TO AN ABNORMAL IRON CONTENT OF THE ORGANISM | |
CA2533763A1 (en) | Cyanoamide compounds useful as malonyl-coa decarboxylase inhibitors | |
KR890000477A (en) | New compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA94 | Acknowledgement of application withdrawn (non-payment of fees) |
Effective date: 20060118 |